Regional Health Care Group (RHCG) is a 100% Australian-owned company that resides within Australia’s most successful privately-owned group of companies in the Healthcare / R&D sector. The group employs > 350 people, enjoys revenues of > AUD$350M p.a. & has achieved strong investment & growth > 30% per annum for the past 6 years. R&D outcomes have been strong, with significant product groups being developed for large multi-national companies including Johnson & Johnson & 3M. The clean-air technology developed by Aeris Pty Ltd now has global reach. Novapharm developed Ioscan - the world's first single unit-dose oral CT contrast media. Nanosonics will launch a new HLD/sterilisation technology platform during 2009.